Efficacy and Safety of Obinutuzumab in Adolescents with Active Lupus Nephritis: Primary Results from POSTERITY, a Phase II Global Trial (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-OR073; Pres time: Oct 24, 2026; 04:30 PM - 04:42 PM; Location: Four Seasons Ballroom 2; "Abstract and presentation is embargoed for release at date and time of presentation."
Clinical • Late-breaking abstract • P2 data • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology
|
|
Marina Vivarelli1; Agustin Remesal12; Louise Oni13,14; Peiqing Yu15; Felix Erblang16; Olga Mitrofanova16; William Franklin Pendergraft17; Patricia B. Lehane18; Deborah Levy2,3; Gabriel Vega Cornejo4; Maria Teresa Terreri5; Aleksandra Zurowska6,7; Adolfina Elizabeth Zuta8; Joan Calzada-Hernández9; Julien Hogan10; Sandra Enciso-Peláez11
|